Structural Characterization of Emerging Synthetic Drugs by Mass Spectrometry

Structural Characterization of Emerging Synthetic Drugs by Mass Spectrometry

This webinar originally occurred on March 5, 2021
Duration: 1 hour


The main focus of this webinar is on the use of isotope labeling, multi-stage mass spectrometry (MSn), ion spectroscopy, and accurate mass measurements with high resolution mass spectrometry to demonstrate some important—but previously unidentified—rearrangement mechanisms in the spectra of cathinones and fentanyl analogs. Although many of these techniques are not available to practitioners, the results provide compelling evidence to support the fragmentation mechanisms and pathways observed every day by practitioners.

We demonstrate two important intermediates in the fragmentation spectra of cathinones like alpha-PVP, both of which are based on a phthalane core. These intermediates are important in understanding the mass spectra of a wide variety of cathinones. We also demonstrate common pathways for the fragmentation of fentanyl analogs and evidence for at least three different structures for the major fragmentation product at m/z 188 in the tandem mass spectra or protonated fentanyl analogs.

Finally, we present a novel algorithm for the comparison of mass spectra, which takes advantage of the fact that the variance in ion abundances of replicate spectra are not independently variable, as has long been assumed. The algorithm uses a general linear regression model (GLM) to predict the ion abundances of each of the 15 most abundant ions in a mass spectrum of a questioned sample. A binary classifier then uses the correctness of the predicted ion abundances to decide whether or not to identity the questioned sample as a particular drug. Using external validation spectra of hundreds of replicate spectra, the algorithm predicts abundances with a precision that is typically five times better than models that assume a fixed exemplar.

Detailed Learning Objectives

  1. Major fragmentation pathways of protonated cathinones
  2. Major fragmentation pathways of protonated fentanyl analogs
  3. Mathematical comparison of fragment ion abundances for drug identifications


  • Glen P. Jackson, Ph.D., FRSC, FAAFS

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at with any questions and subscribe to our newsletter for notifications.

Related Content

Medicolegal Death Investigation Partnerships on Overdose Fatality Reviews

Date July 2022 Overview The main purpose of Overdose Fatality Reviews (OFRs) is to review overdose fatalities and find gaps in services to help save lives. They rely on a multi-agency approach to information sharing to accomplish this goal. Upon…

An Introduction to Drug Checking and its Role in Harm Reduction

Date July 2022 Overview Harm reduction is a set of strategies to help reduce health complications stemming from drug consumption. Harm reduction organizations provide resources that educate people who use drugs (and their family and friends) about safe drug use…

Project ECHO: Applications for the Medicolegal Death Investigation Community and Other Forensic Disciplines

Date October 2022 Overview Similar to the foundational ECHO model designed for primary care providers, ECHO: Overdose Fatality Investigation Techniques (OD-FIT) is designed to promote the rapid dissemination of medicolegal death investigation-specific knowledge for immediate application to overdose casework.1 The ECHO…